Lord, Abbett & Co
NUVA

Lord, Abbett & Co’s NuVasive, Inc. NUVA Stock Holding History

Lord, Abbett & Co’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-8,573
Closed -$357K – 602
2023
Q2 		$357K Hold
8,573
– – ﹤0.01% 531
2023
Q1 		$354K Hold
8,573
– – ﹤0.01% 530
2022
Q4 		$354K Buy
+8,573
New +$347K ﹤0.01% 563
2021
Q4 		– Sell
-697,672
Closed -$41.8M – 701
2021
Q3 		$41.8M Buy
697,672
+18,810
+3% +$1.16M 0.1% 299
2021
Q2 		$46M Sell
678,862
-197,679
-23% -$13.5M 0.11% 276
2021
Q1 		$57.5M Buy
876,541
+59,862
+7% +$3.59M 0.15% 213
2020
Q4 		$46M Sell
816,679
-232,114
-22% -$11.4M 0.12% 264
2020
Q3 		$50.9M Sell
1,048,793
-35,366
-3% -$1.91M 0.16% 202
2020
Q2 		$60.3M Buy
1,084,159
+209,079
+24% +$12.1M 0.21% 145
2020
Q1 		$44.3M Buy
+875,080
New +$58.7M 0.2% 159
2016
Q4 		– Sell
-44,246
Closed -$2.95M – 973
2016
Q3 		$2.95M Sell
44,246
-59,857
-57% -$3.81M 0.01% 805
2016
Q2 		$6.22M Buy
104,103
+20,907
+25% +$1.13M 0.02% 668
2016
Q1 		$4.05M Buy
83,196
+34,574
+71% +$1.57M 0.01% 748
2015
Q4 		$2.63M Sell
48,622
-56,852
-54% -$2.9M 0.01% 820
2015
Q3 		$5.09M Buy
+105,474
New +$5.45M 0.02% 735

Other funds holding NUVA

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Lord, Abbett & Co's NUVA Position: Q3 2023 in Review

Lord, Abbett & Co sold out of NuVasive, Inc. (NUVA) in Q3 2023, closing a stake of 8,573 shares — an estimated $357K sold.

Lord, Abbett & Co first reported a position in NUVA in Q3 2015 and held it in 15 quarters. The position peaked at $60.3M in Q2 2020. 2 funds tracked by Wall St. Rank hold NUVA as of Q3 2023.

  • Lord, Abbett & Co reported no remaining NuVasive, Inc. position as of Q3 2023 after selling out during the quarter.
  • Lord, Abbett & Co sold 8,573 NuVasive, Inc. shares in Q3 2023, an estimated $357K.
  • Lord, Abbett & Co first reported a position in NuVasive, Inc. in Q3 2015 and held it in 15 quarters.
  • Lord, Abbett & Co's NuVasive, Inc. position peaked at $60.3M in Q2 2020.
  • 2 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2023.

Based on Lord, Abbett & Co's 13F filing for Q3 2023, filed 13 Nov 2023.